Le Lézard
Classified in: Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023


Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that financial results for the first quarter of fiscal year 2023 will be released before the market opens on Thursday, May 11th.

Management will host a conference call at 8:00 a.m. Eastern Time on May 11th to discuss the results of the quarter, and to host a question and answer session. To listen to the call by phone, interested parties may dial 877-407-8289 (or 201-689-8341 for international callers) and provide access code 13737575. Participants should ask for the Apyx Medical Corporation Call. A live webcast of the call will be accessible via the Investor Relations section of the Company's website and at:

https://event.choruscall.com/mediaframe/webcast.html?webcastid=gfBZBEow

A telephonic replay will be available approximately two hours through the following two weeks. The replay can be accessed by dialing 877-660-6853 for U.S. callers or 201-612-7415 for international callers and using the replay access code: 13737575. The webcast will be archived on the Investor Relations section of the Company's website.

About Apyx Medical Corporation:

Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people's lives through innovative products, including its Helium Plasma Technology products marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The Company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at www.ApyxMedical.com.


These press releases may also interest you

at 15:30
Roblox Corporation Sued for Securities Law Violations - Contact the Rosen Law Firm before August 12, 2024 to Discuss Your Rights - RBLX
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Roblox Corporation between November 15, 2023 and May 8, 2024, both dates inclusive (the "Class Period"), of the important August 12, 2024 lead plaintiff...

at 14:50
AESO Board Announcement: Leadership Transition and Departure of Michael Law
The Alberta Electric System Operator (AESO) Board announced today that Michael Law, President and Chief Executive Officer, will leave the organization, effective August 1, 2024. Law first joined the AESO in 2009 as Vice-President, Operations and was...

at 14:19
Hamilton ETFs Opens the Market
Jennifer Mersereau, Senior Partner, Co-Founder & COO, Hamilton ETFs, Patrick Sommerville, Senior Partner, Head of Business Development, Hamilton ETFs, and their team joined Keith Wu, Head, Exchange Traded Products, Toronto Stock Exchange , to open...

at 14:03
Maximizing Efficiency and Innovation in Food & Beverage Manufacturing Through Exponential IT Transformation: New Research From Info-Tech Research Group
New research insights from Info-Tech Tech Research Group will equip food and beverage manufacturers with essential strategies for embracing digital transformation. The global research and advisory firm explains that the industry can significantly...

at 13:50
Canadian General Investments: Investment Update - Unaudited
Canadian General Investments, Limited (CGI)  (LSE: CGI) reports on an unaudited basis that its net asset value per share (NAV) at June 30, 2024 was $62.50, resulting in year-to-date and 12-month NAV returns, with dividends reinvested, of 13.3% and...

at 13:40
Participation in Special Olympics Linked to Reduced Risk of Diabetes Among Individuals With Intellectual and Developmental Disabilities
New research led by the Faculty of Health Sciences at Ontario Tech University and published in Diabetic Medicine, reveals participation in Special Olympics programming is associated with a significantly lower risk of diabetes among adults with...

More news about Business...


News published on and distributed by: